Lymph node metastasis is almost always synonymous with cancer progression, but in this fantastic study from @ubellackerlab.bsky.social, they reveal that it also imparts a key metabolic vulnerability: FSP1 dependency. Congrats Jess and @mariopalma.bsky.social!

Evolution Under Therapy: Resistance Mechanisms— Andrew J. Aguirre, Nathan Reticker-Flynn, Susan M. Rosenberg, and Kathleen Burkhardt will address this topic in a plenary at the AACR Special Conference on Cancer Evolution (Dec 4-6; Albuquerque). buff.ly/4ecfgxE #AACRevol25 @retickerflynn.bsky.social

Hot off the presses! Was an honor to team up with Scott Dixon @stanforduniversity.bsky.social on this Nature Cancer review. We reflect on hurdles that have slowed translation of ferroptosis-directed therapies and share ideas on what it will take to bring these therapies to the clinic. rdcu.be/eBbqV

Interested in studying lymph node metastasis? Check out our protocol by Cort Breuer out today in @natprot.nature.com bsky.app/profile/nat...

Our lab has an opening for a new Research Assistant (LSRP) starting this Summer/Fall. If you're interested in joining a vibrant community working at the interfaces of cancer metastasis and adaptive immunity, apply here: careersearch.stanford.edu/jobs/life-sc...

Excited to share this work from the Garcia Lab out today in @naturecomms.bsky.social! We engineer "cytokine adaptors", molecular immune switches that simultaneously block a target cytokine while inducing local activation of alternative cytokine receptors. rdcu.be/ec7GS

First Bluesky post! If you're interested in hearing about our work, check out this seminar in a couple weeks.